Biodistribution Assessment for Gene Therapies

Assessing the biodistribution of gene therapies requires a highly sensitive approach, as even small amounts of material can have significant and long-lasting impacts on physiological processes.

With strong resilience to contaminants and superior multiplex capacity, ITR’s droplet digital PCR (ddPCR) services can generate precise and accurate bioanalytical and biodistribution data down to the femtomolar range for your gene therapy product.